Editorial: safety and efficacy of infliximab and corticosteroids in checkpoint inhibitor-induced colitis—authors' reply

Emilie K. Dahl*, Osama K. Abed, Jens Kjeldsen, Marco Donia, Inge M. Svane, Anders Dige, Jørgen S. Agnholt, Jacob T. Bjerrum, Jakob B. Seidelin

*Corresponding author for this work

Research output: Contribution to journalContribution to newspaper - Comment/debate

Original languageEnglish
JournalAlimentary Pharmacology & Therapeutics
Volume57
Issue number1
Pages (from-to)152-153
ISSN0269-2813
DOIs
Publication statusPublished - Jan 2023

Keywords

  • Adrenal Cortex Hormones/adverse effects
  • Colitis/chemically induced
  • Humans
  • Infliximab/adverse effects

Cite this